Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PEOPLE - Cepheid (US) elects to the board:

This article was originally published in Clinica

Executive Summary

Sunnyvale, California-based DNA technology company Cepheid has announced the election of David Persing and Mitchell Mroz to its board of directors. Mr Persing is currently vice-president of discovery research at immunotherapeutics company Corixa, and Mr Mroz is currently chairman of the board of financial institution Northrop Grumman's Federal Credit Union.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT058434

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel